Analysis of ANC Levels after Filgrastim Therapy in Acute Leukemia Children with Neutropenia
Cytotoxic chemotherapy suppresses the hematopoietic system, and the most serious hematologic toxicity is neutropenia. This can decrease a risk of infection that causes delays in treatment and reduction of dose intensity, which reduces therapeutic outcome. Filgrastim is used to increase neutrophils l...
Main Authors: | Reta Anggraeni Widya, Susanto Nugroho, Sri Winarsih, Yulistiani Yulistiani |
---|---|
Format: | Article |
Language: | English |
Published: |
Universitas Airlangga
2021-01-01
|
Series: | Folia Medica Indonesiana |
Subjects: | |
Online Access: | https://e-journal.unair.ac.id/FMI/article/view/24287 |
Similar Items
-
Kadar Procalcitonin pada Anak dengan Demam Neutropenia
by: Finia Cahayasari, et al.
Published: (2016-11-01) -
Biosimilars in the management of neutropenia: focus on filgrastim
by: Caselli D, et al.
Published: (2016-02-01) -
Biosimilar filgrastim vs filgrastim: a multicenter nationwide observational bioequivalence study in patients with chemotherapy-induced neutropenia
by: Sevinç A, et al.
Published: (2018-01-01) -
Home administration of filgrastim (Nivestim™) in primary prophylaxis of chemotherapy-induced febrile neutropenia
by: Otremba B, et al.
Published: (2018-10-01) -
Lenograstim and filgrastim in the febrile neutropenia prophylaxis of hospitalized patients: efficacy and cost of the prophylaxis in a retrospective survey
by: Innocenti R, et al.
Published: (2018-12-01)